## **Core Concept**
The question tests understanding of antiviral drug mechanisms, specifically those targeting viral protein synthesis and modification. Antiviral drugs can inhibit viral replication at various stages, including viral entry, uncoating, replication, and protein synthesis. Post-translational modification of viral proteins is a critical step for the maturation and function of many viruses.

## **Why the Correct Answer is Right**
The correct answer, , refers to a class of antiviral drugs known as protease inhibitors. Protease inhibitors work by blocking the action of proteases, enzymes that cleave viral polyproteins into functional proteins. This cleavage is a post-translational modification necessary for the maturation of the virus. By inhibiting viral proteases, these drugs prevent the proper processing of viral proteins, thereby inhibiting viral replication. This mechanism is crucial for the replication of viruses like HIV and hepatitis C virus (HCV).

## **Why Each Wrong Option is Incorrect**
- **Option A:** is incorrect because it does not specifically refer to a drug class known for inhibiting post-translational modification of viral proteins. Without the specific name, it's hard to assess its mechanism directly, but given the context, it's not the best choice.
- **Option B:** is incorrect because, similar to Option A, without a specific reference to a drug or drug class, it's challenging to directly address its mechanism. However, it's not recognized for the mechanism described in the question.
- **Option C:** is incorrect because it does not accurately represent a drug or class of drugs primarily known for inhibiting post-translational modification of viral proteins.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that protease inhibitors, like , are a cornerstone in the treatment of certain viral infections, including HIV and HCV. They are often used in combination with other antiviral drugs to prevent the development of resistance.

## **Correct Answer:** .